Rimax Pharmaceuticals Private Limited
About Rimax Pharmaceuticals Private Limited
Data last updated:
Rimax Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2016PTC088144.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudipta Das and Sidhartha Sekhar Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bs – 7 Basement Ansal'S Sundaram Rdc Raj Nagar Ghaziabad, Uttar Pradesh, India – 201001.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.11 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹2,521 (net margin 0.2%) and EBITDA of ₹4,685 (EBITDA margin 0.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rimax Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBs – 7 Basement Ansal'S Sundaram Rdc Raj Nagar Ghaziabad, Uttar Pradesh, India – 201001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rimax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rimax Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rimax Pharmaceuticals Private Limited, buy the company report.
Financials of Rimax Pharmaceuticals Private Limited
FY 2025 filings availableRimax Pharmaceuticals Private Limited reported revenue of ₹12.11 Lakh (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 1% in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,685 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,521 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rimax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rimax Pharmaceuticals Private Limited
Rimax Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudipta Das | Director | 06 Dec 2016 | 9 Years 10 Months | Current |
| Sidhartha Sekhar Sinha | Director | 06 Dec 2016 | 9 Years 10 Months | Current |
Auditor
Rimax Pharmaceuticals Private Limited is audited by GAURAV SHARMA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV SHARMA & CO | FY 2019 | 020643C |
Shareholding
The shareholding of Rimax Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rimax Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rimax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rimax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rimax Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rimax Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Sidhartha Sekhar Sinha was appointed as Director on 06 Dec 2016.
Frequently asked questions
Rimax Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 December 2016 (10+ years old) and is registered under CIN U51909UP2016PTC088144.
Rimax Pharmaceuticals has 2 current directors:
- Sudipta Das - Director
- Sidhartha Sekhar Sinha - Director
The latest financial statements of Rimax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Rimax Pharmaceuticals is U51909UP2016PTC088144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rimax Pharmaceuticals was incorporated on 06 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Sidhartha Sekhar Sinha was appointed as Director on 06 Dec 2016. Sudipta Das was appointed as Director on 06 Dec 2016.
The registered office of Rimax Pharmaceuticals is at Bs – 7 Basement AnsalS Sundaram Rdc Raj Nagar Ghaziabad, Uttar Pradesh, India – 201001.
Rimax Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Rimax Pharmaceuticals is compliant as of 22 July 2026. The company is actively filing with the Registrar of Companies.
Rimax Pharmaceuticals can be reached at its registered office: Bs – 7 Basement AnsalS Sundaram Rdc Raj Nagar Ghaziabad, Uttar Pradesh, India – 201001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
